CAH241129P60000
- 0.05
- 0.000.00%
Cardinal Health Newsroom
Jefferies Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $125
J.P. Morgan Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $132
J.P. Morgan Remains a Hold on Cardinal Health (CAH)
JPMorgan Adjusts Price Target on Cardinal Health to $132 From $123, Maintains Neutral Rating
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Maintains Target Price $101
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $101 to $138
Cardinal Health's Strategic Acquisitions and Financial Strength Drive Buy Rating
Evercore ISI Remains a Hold on Cardinal Health (CAH)
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $124 to $139
Cardinal Health Is Maintained at Overweight by Barclays
Cardinal Health's Strong Pharmaceutical Growth and Strategic Moves Justify Buy Rating
Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $133
TD Cowen Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $130
UBS Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $134
Cardinal Health Is Maintained at Buy by UBS
Cardinal Health Analyst Ratings
Nephron Research Adjusts Price Target on Cardinal Health to $130 From $122
Evercore Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $125
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Cardinal Health (CAH) and Sanofi (OtherSNYNF)
Deutsche Bank Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $119